Clincosm LogoSign in Get a demo

Ocular Physiology

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ocular Physiology Trial in Jacksonville (Acuvue Oasys 1 Day for Astigmatism with Legacy lidstock, Acuvue Oasys 1 Day for

Not yet recruiting
  • Ocular Physiology
  • Acuvue Oasys 1 Day for Astigmatism with Legacy lidstock
  • Acuvue Oasys 1 Day for Astigmatism with Amcor laminated lidstock
  • Jacksonville, Florida
    VRC
Jan 26, 2023

Ocular Physiology Trial in United States (TEST LENS, CONTROL LENS)

Not yet recruiting
  • Ocular Physiology
  • TEST LENS
  • CONTROL LENS
  • Longwood, Florida
  • +5 more
Aug 12, 2022

Ocular Physiology Trial in United States (TEST LENS, CONTROL LENS)

Recruiting
  • Ocular Physiology
  • TEST LENS
  • CONTROL LENS
  • Jacksonville, Florida
  • +5 more
Aug 8, 2022

Ocular Physiology Trial in United States (PRECISION1® for Astigmatism Contact Lenses, MyDay® Toric Soft Contact Lenses)

Completed
  • Ocular Physiology
  • PRECISION1® for Astigmatism Contact Lenses
  • MyDay® Toric Soft Contact Lenses
  • Jacksonville, Florida
  • +4 more
Jun 13, 2022

Ocular Physiology, Optic Disk, Regional Blood Flow Trial in Vienna (drug, device, procedure)

Withdrawn
  • Ocular Physiology
  • +2 more
  • NG-monomethyl-L-arginine (L-NMMA)
  • +6 more
  • Vienna, Austria
    Department of Clinical Pharmacology, Medical University of Vienn
Aug 13, 2019

Ocular Physiology, Intraocular Pressure, Regional Blood Flow Trial in Vienna (Latanoprost 0.005%, Xalatan®, Placebo)

Completed
  • Ocular Physiology
  • +2 more
  • Latanoprost 0.005%, Xalatan®
  • Placebo
  • Vienna, Austria
    Department of Clinical Pharmacology
Jun 7, 2018

Short Term and Day to Day Reproducibility of Reflectometric

Withdrawn
  • Ocular Physiology
  • Measurement of oxygen saturation of retinal vessels with optical reflectometer
  • Vienna, Austria
    Medical University of Vienna
Jun 7, 2018

Ocular Physiology, Intraocular Pressure Trial in Vienna (Brimonidine 0.2 %)

Withdrawn
  • Ocular Physiology
  • Intraocular Pressure
  • Brimonidine 0.2 %
  • Vienna, Austria
    Department of Clinical Pharmacology
Nov 20, 2014

Ocular Physiology, Regional Blood Flow Trial in Vienna (NG-monomethyl-L-arginine)

Terminated
  • Ocular Physiology
  • Regional Blood Flow
  • Vienna, Austria
    Department of Clinical Pharmacology
Nov 14, 2014

Retina, Ocular Physiology Trial in Vienna (latanoprost 0.005% + timolol 0,5% fixed combination, brimonidine 0,2% + timolol 0,5%

Completed
  • Retina
  • Ocular Physiology
  • latanoprost 0.005% + timolol 0,5% fixed combination
  • brimonidine 0,2% + timolol 0,5% fixed combination
  • Vienna, Austria
    Department of Clinical Pharmacology
Nov 13, 2014

Nidek Optical Coherence Tomography RS-3000 for 3D Measurements

Completed
  • Ocular Physiology
    • La Jolla, California
    • +2 more
    Jan 16, 2014

    Genetic Polymorphism, Macular Degeneration, Regional Blood Flow Trial in Vienna (Squatting)

    Completed
    • Genetic Polymorphism
    • +3 more
    • Squatting
    • Vienna, Austria
      Department of Clinical Pharmacology, Medical University of Vienn
    Mar 15, 2013

    Blood Flow Velocity, Autoregulation, Ocular Physiology Trial in Vienna (Yohimbine HCl)

    Completed
    • Blood Flow Velocity
    • +2 more
    • Yohimbine hydrochloride
    • Vienna, Austria
      Department of Clinical Pharmacology, Medical University of Vienn
    Dec 22, 2008

    Ocular Physiology, Microcirculation Trial in Vienna (Adenosine, Placebo)

    Completed
    • Ocular Physiology
    • Microcirculation
    • Vienna, Austria
      Department of Clinical Pharmacology, Medical University of Vienn
    Jul 8, 2008

    Ocular Physiology, Regional Blood Flow Trial in Vienna (vitamin C (Mayrhofer) 24mg/min i.v. for 64 min, Placebo, 100% O2 (AGA)

    Completed
    • Ocular Physiology
    • Regional Blood Flow
    • vitamin C (Mayrhofer) 24mg/min i.v. for 64 min
    • +2 more
    • Vienna, Austria
      Department of Clinical Pharmacology
    Jul 9, 2008

    Ocular Physiology, Regional Blood Flow Trial in Vienna (Nifedipine (drug), L-Arginin (drug), Placebo)

    Completed
    • Ocular Physiology
    • Regional Blood Flow
    • Nifedipine (drug)
    • +2 more
    • Vienna, Austria
      Department of Clinical Pharmacology
    Jul 8, 2008

    Regional Blood Flow, Ocular Physiology Trial in Vienna (Quetiapine (drug), Sulpiride (drug), Placebo)

    Completed
    • Regional Blood Flow
    • Ocular Physiology
    • Quetiapine (drug)
    • +2 more
    • Vienna, Austria
      Department of Clinical Pharmacology
    Jul 8, 2008

    Ocular Physiology, Retina, Blood Flow Velocity Trial in Vienna (flicker light stimulation)

    Completed
    • Ocular Physiology
    • +2 more
    • flicker light stimulation
    • Vienna, Austria
      Department of Clinical Pharmacology
    Jul 1, 2008

    Regional Blood Flow, Ocular Physiology, Retina Trial in Vienna (Moxaverine, Moxaverin 150mg, NaCl)

    Completed
    • Regional Blood Flow
    • +2 more
    • Vienna, Austria
      Department of Clincal Pharmacology, Medical University of Vienna
    Jul 2, 2008

    Ocular Physiology, Regional Blood Flow Trial in Vienna (indometacine (drug) effect on ocular blood flow)

    Completed
    • Ocular Physiology
    • Regional Blood Flow
    • indometacine (drug) effect on ocular blood flow
    • Vienna, Austria
      Department of Clinical Pharmacology
    Feb 9, 2007

    Ocular Physiology, Regional Blood Flow Trial in Vienna (Clonidin, Brimonidine)

    Completed
    • Ocular Physiology
    • Regional Blood Flow
    • Vienna, Austria
      Department of Clinical Pharmacology
    Feb 9, 2007

    HIV, Retina, Ocular Physiology Trial in Vienna (100% O2)

    Completed
    • HIV Infections
    • +2 more
    • 100% O2
    • Vienna, Austria
      Department of Clinical Pharmacology, Medical University of Vienn
    Feb 5, 2007

    Regional Blood Flow, Ocular Physiology Trial in Vienna (Phenylephrine, NG-Monomethyl-L-Arginine, Propanolol)

    Completed
    • Regional Blood Flow
    • Ocular Physiology
    • Vienna, Austria
      Department of Clinical Pharmacology, Medical University of Vienn
    Feb 2, 2007